<DOC>
	<DOCNO>NCT02895529</DOCNO>
	<brief_summary>The purpose study investigate hypothesis efficacy intravenous ( IV ) itraconazole follow oral itraconazole non-inferior intravenous caspofungin empiric therapy suspect fungal infection participant fever neutropenia .</brief_summary>
	<brief_title>A Study Comparing Efficacy Intravenous Followed Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy Neutropenic Participants With Hematological Malignancy</brief_title>
	<detailed_description />
	<mesh_term>Hematologic Neoplasms</mesh_term>
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Participant must hospitalize hematologic malignancy treat myelosuppressive therapy and/or Hematopoietic stem cell transplantation Participant must diagnosis neutropenia neutrophil count &lt; 500/microliters ( mcL ) ( 0.5 Ã— 10^9/ liter [ L ] ) least 96 hour screen Participant must diagnosis fever meet follow criterion : 1 ) Body temperature great ( &gt; ) 38 degree celsius ( 38 degree celsius oral rectal measurement ; 37.5 degree celsius axillary measurement ) consider related blood product transfusion drug fever , 2 ) Not respond broadspectrum grampositive gramnegative antibiotic 47 day without sign symptom potentially attributable deep fungal infection 3 ) Defervescence within 3 day first broadspectrum antibiotic recurrence afterwards . A woman childbearing potential must negative serum ( beta human chorionic gonadotropin [ b hCG ] ) urine pregnancy test screen A woman must agree donate egg ( ovum , oocytes ) purpose assist reproduction study period menstrual period follow end study treatment Is concomitantly use systematic antifungal drug Has inadequately manage bacterial infection Is currently receive Cytochrome P450 3A4 ( CYP3A4 ) metabolized/Pglycoproteintransported drug ( include limit cisapride , pimozide , quinidine , dofetilide , levacetylmethadol , terfenadine , astemizole , mizolastine , bepridil , sertindole , 3hydroxy3methylglutarylcoenzyme A reductase ( HMGCoA reductase ) inhibitor [ example , simvastatin , lovastatin ] , oral midazolam , triazolam , ergot alkaloid [ eg , dihydroergotamine , ergonovine , ergotamine , methylergonovine ] nisoldipine ) prohibit study Has know allergy , intolerance hypersensitivity azole antifungal excipients Has contraindication use sodium chloride injection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>